FOR IMMEDIATE RELEASE
inSeption Group Co-Founder Brian Sulpizio to Deliver Opening Remarks at Philadelphia Business Journal’s State of the Biotech Industry Event
PHILADELPHIA, PA – October 19, 2026 – inSeption Group, a Philadelphia-based clinical outsourcing company, is proud to sponsor the Philadelphia Business Journal’s State of the Biotech Industry event on Thursday, October 22, 2026. Brian Sulpizio, Co-Founder and Managing Partner of inSeption Group, will deliver opening remarks ahead of a panel discussion featuring some of the region’s most influential life sciences leaders.
The event will bring together executives, researchers, and industry stakeholders to explore the latest developments shaping the Philadelphia region’s biotechnology sector, from groundbreaking scientific advances to the evolving regulatory and business landscape.
In his remarks, Sulpizio will reflect on the people behind the progress, emphasizing that while scientific innovation drives the industry forward, it takes the collective expertise, dedication, and collaboration of an entire life sciences community to bring promising therapies to patients.
“I’ve spent more than 30 years in drug development outsourcing, and one thing has never changed: it ultimately comes down to the people doing the work,” said Sulpizio. “From scientists and investors to clinical research professionals and sponsors, every person plays a role in moving science forward. Here in Philadelphia, we bring a little extra grit to that equation. We roll up our sleeves, tackle challenges together, and find a way forward.”
Founded by industry veterans, inSeption Group provides flexible, cross-functional clinical outsourcing services to biotechnology and pharmaceutical companies, with particular expertise in complex development programs. Headquartered in the Philadelphia region, the company has built its reputation on experienced teams, continuity, accountability, and a commitment to treating its clients’ programs as its own.
“We’re fortunate to be part of an industry where the work we do has the potential to make a meaningful difference in patients’ lives,” added Sulpizio. “We may come from different organizations and disciplines, but we share that common purpose. The strength of Philadelphia’s life sciences community has always been its people, and that’s what gives me so much confidence in what we can accomplish together.”
The State of the Biotech Industry event will be moderated by Philadelphia Business Journal healthcare reporter John George and will feature perspectives from leaders across the region’s biotechnology, research, and pharmaceutical communities.
About inSeption Group
inSeption Group is a Philadelphia-based, cross-functional clinical outsourcing company providing flexible, high-quality solutions to biotechnology and pharmaceutical organizations. With deep expertise across Clinical Operations, Medical Writing, Regulatory Operations, Quality and Compliance, Drug Safety, Data Management, and Biostatistics, inSeption combines experienced professionals with adaptable engagement models to help sponsors navigate complex clinical development programs. Built on a foundation of integrity, accountability, and continuity, inSeption is committed to protecting its clients’ assets as its own.
Learn more at www.inseptiongroup.com.
For media inquiries, contact:
Kristin Morris
Senior Director, Corporate Communications
267-397-8980